Skip to Content
 
Center for International Blood and Marrow Transplant Research

GS17-02

Main Content

Myeloablative vs reduced intensity conditioning in haploidentical transplantation.

Study #: GS17-02

Study Status: Published

Presentation(s)

2018, ASH (Oral)

Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.

Citation

Solomon SR, St. Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang M-J, Eapen M.

Blood Advances. 2019, Oct 08: 3(19): 3(19):2836-2844. doi: 10.1182/bloodadvances.2019000627. Epub 2019, Oct 03. PMCID:PMC6784523.

PubMed

PMID: 31582392

Abstract